General Practice Doctors in Paterson, NJ Accepting Medicare

2 General Practice doctors found. Showing 1 - 2

Todd Preston Pierce, M.D General Practice Medicare: Not Enrolled in Medicare Practice Location: 703 Main St Dept Of, Paterson, NJ 07503 Phone: 973-754-2000

Mr. Mahesh M Mehta, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 426 10th Ave, Paterson, NJ 07514 Phone: 973-345-9595    Fax: 973-345-6996

News Archive

One billion non-Medicare billings are processed yearly, says expert

The U.S. remains on track to spend twice as much for health care as for food, yet millions are without insurance or uninsured.

UMass Amherst study explores effects ER caregivers' on-the-job emotions on patient care

Doctors and nurses in emergency departments at four academic centers and four community hospitals in the Northeast reported a wide range of emotions triggered by patients, hospital resources and societal factors, according to a qualitative study led by a University of Massachusetts Amherst social psychologist.

Asthma or allergies in an expectant mother may increase the likelihood that her child will exhibit symptoms of autism

This association between a mother's asthma and allergies and a child's autism has not been reported in the medical literature previously, says Dr. Croen, and requires replication in further studies.

Researchers receive $1M grant to research in biological components with solid-state electronics

​An interdisciplinary team of researchers from Columbia University, led by Ken Shepard, professor of electrical engineering and biomedical engineering at Columbia Engineering and including Virginia W. Cornish, Helena Rubinstein Professor of Chemistry, and Lars Dietrich, assistant professor of biological sciences, has won a prestigious $1 million three-year grant from the W. M. Keck Foundation to advance their research in combining biological components with solid-state electronics, creating new systems that exploit the advantages of both.

IMBio receives regulatory concurrence from FDA to market OCL 500 microspheres in the U.S.

IMBiotechnologies Ltd., a privately held biotechnology company focused on developing medical device products for use in the area of embolotherapy, today announced that it has received regulatory concurrence from the United States Food and Drug Administration to market its lead product, Occlusin 500 Artificial Embolization Device in the U.S. for the treatment of unresectable/inoperable hypervascularized tumours.

Read more Medical News

› Verified 2 days ago